ArticleClinical and vaccine immunology : CVI2015

Reply to "Use of the LC16m8 Smallpox Vaccine in Immunocompromised Individuals Is Still Too Risky".

Hiroyuki Yokote et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.